Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte versus Tetraspan during cardiopulmonary bypass in valvular cardiac surgery
NL-OMON21191Suspended
- Sponsor
- UZ Brussel
- Start
- Dec 2011
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of hetastarch and hydroxyethyl starch 130/0.42 in Cardiac valve disease (VHD) (2 arms), sponsored by UZ Brussel. Primary endpoints: Coagulation status, Colloid osmotic pressure and 1 more. Started Dec 2011; status: suspended.
02
Drugs
hetastarchhydroxyethyl starch 130/0.42
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on NL-OMON21191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21191.